Hook - thesis
Pagaya has quietly moved from speculative growth fintech to a business showing durable cash generation. Recent company results show network volume up 33% year-over-year, revenue growth around 19% in the latest reported quarter, and adjusted EBITDA expanding by roughly 43% — a combination that translated into positive free cash flow and net income in 2026. At a market cap of roughly $1.72 billion and an EV/EBITDA near 7.3x, the market is not paying a premium for that improving profitability.
My thesis is straight-forward: if Pagaya sustains asset-backed securities (ABS) issuance, keeps growing its originations network, and converts scale into operating leverage, the stock should rerate from what looks like a conservative multiple today. That makes this a mid-term, actionable long trade for investors willing to hold through incremental execution risk.
What Pagaya does and why it matters
Pagaya builds AI and data networks for the financial industry to evaluate loan applications in real time. Practically that means the company partners with banks and lenders, sources loan flows across multiple consumer credit products, packages those loans into asset-backed securities, and monetizes both origination fees and ancillary analytics/IP licensing.
Why the market should care: Pagaya sits at the intersection of three durable trends. First, lenders are outsourcing data science and AI underwriting to specialist platforms instead of building complex models in-house. Second, ABS markets remain a deep pool of institutional demand when performance is solid and underwriting is tight. Third, Pagaya's multi-product expansion - including new buy-now-pay-later deals and increased funding capacity - means more diversified revenue streams, less single-product concentration, and stronger economics as scale compounds.
Hard numbers that support the bullish case
Use the following reported results and metrics to anchor the thesis:
- Reported revenue was approximately $1.3 billion (reported comparison vs peers), with net income around $81.4 million in the most recent annual tally cited in public reports.
- Management reported network volume growth of ~33% year-over-year in the most recent quarter, and revenue growth of roughly 19% year-over-year.
- Adjusted EBITDA expanded by about 43% year-over-year in the last quarter, indicating improving operating leverage.
- Pagaya reported accelerating ABS sales - over $5.5 billion in ABS completed during the first half of 2026 and several billion more of funding in Q2 (about $3.7B referenced for the quarter), which both stabilizes funding and generates fee revenue.
- Free cash flow is healthy: $251,779,000 in the most recent snapshot — a meaningful cash cushion for a company of this size.
Valuation framing
Valuation metrics paint Pagaya as a value-oriented growth company today. Market capitalization is about $1.72 billion and enterprise value is roughly $2.34 billion. Key multiples include:
| Metric | Value |
|---|---|
| Market Cap | $1,715,653,160 |
| Price / Earnings | ~13.99x (trailing) |
| Price / Sales | ~1.29x |
| EV / EBITDA | ~7.3x |
| Free Cash Flow (most recent) | $251,779,000 |
Those multiples are conservative relative to high-growth AI/fintech names. The case for rerating rests on continued revenue growth + margin expansion. With positive free cash flow already in hand and rising operating leverage, a move from current EV/EBITDA into the mid-teens (on improved growth visibility) would justify substantially higher market prices.
Technical and sentiment backdrop
Technicals are neutral-to-cautious at the moment: the 10- and 20-day SMAs sit around $21.46 and $21.64; the 50-day SMA is roughly $20.08. RSI is near 47, indicating no extreme conditions. Short interest has trended down from mid-2026 highs (short interest peaked above 14M shares in May-June) to about 10.4M as of 08/31/2026, with days-to-cover moving between ~2.5 and 4.8 depending on average volume. A declining short base reduces one potential source of downside risk while leaving room for a squeeze if fundamentals surprise positively.
Catalysts to watch (2-5)
- Continued ABS issuance and funding partnerships - more ABS supply at acceptable spreads supports fee revenue and repeatable liquidity.
- Quarterly network volume and revenue prints that meet or exceed the ~33% volume and ~19% revenue growth pace reported in the most recent quarter.
- Further margin expansion and positive guidance on adjusted EBITDA and free cash flow for the full year.
- New product rollouts and partnerships (e.g., buy-now-pay-later deals) that diversify fee pools and reduce concentration risk.
- Insider buying: the CEO added to his position on 06/24/2026, a behavioral signal consistent with management conviction.
Trade plan (actionable)
Direction: Long
Entry: $20.50
Target: $30.00
Stop-loss: $17.00
Horizon: mid term (45 trading days) - I expect visible evidence of ABS issuance and a reaffirmation of revenue/margin trajectory over the next 6-9 weeks. That horizon gives the company two reporting milestones or one print plus follow-on issuance windows, which should be enough time for the market to digest operational improvements and reprice the shares.
Rationale: Entry near $20.50 gives a modest buffer below near-term moving averages and current prints. $30.00 is a pragmatic target that assumes a rerating toward higher EV/EBITDA and P/S multiples as revenue growth and margins confirm a sustainable trend. The stop at $17.00 limits downside if volume or ABS distribution stalls or if macro spreads widen materially.
Risks and counterarguments
- Funding and ABS market risk: Pagaya depends on active ABS markets. If institutional demand softens or spreads widen, ABS issuance could slow and fee revenue compress. This is the single largest execution risk.
- Underwriting and credit risk: AI models can underperform in stress periods. Elevated delinquencies in underlying pools would directly impair securitizations and may reduce investor appetite, pressuring both revenue and valuation.
- Concentration and business-model transitions: While Pagaya has diversified, the business still requires execution in new products (e.g., BNPL). Failure to scale these products or overreliance on a few funding partners would be negative.
- Macro and rates: Higher-for-longer rates can push discount rates up and widen ABS spreads; tightening financial conditions would both slow originations and reduce ABS pricing.
- Counterargument: The case for a rerate rests on sustained ABS demand and stable credit performance. If revenue growth slows below current momentum or if adjusted EBITDA growth decelerates, then current multiples may already be reflective of the true risk-adjusted outlook and the stock could trade sideways or lower.
What would change my mind
I would become more bullish if Pagaya reports two consecutive quarters of revenue growth above 20% with adjusted EBITDA margins improving materially and repeatable ABS issuance at attractive pricing. Conversely, I would downgrade the trade if ABS issuance stalls, credit performance materially deteriorates, or management guides to lower-than-expected revenue for the next two quarters.
Final take
Pagaya is a pragmatic AI-fintech with real cash flow and improving margins. The combination of network volume growth, large ABS execution in H1 2026, positive free cash flow, and a conservative current valuation creates an asymmetric trade opportunity for the mid-term investor. The trade plan above balances upside potential against the key execution risks of ABS markets and credit cycles. Place a disciplined position at the entry, watch ABS issuance cadence and quarterly prints, and use the stop-loss to protect capital if the operational story breaks.
Key near-term items to watch: next quarterly volume/revenue print, any announced ABS placements, updates on new product uptake, and movement in ABS spreads.